Recruiting
Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
NCT05727176
- Conditions
- Adenocarcinoma, Advanced Cholangiocarcinoma, Carcinoma, +6 more
- Locations
-
- University of California San Diego UCSD - Moores Cancer Center La Jolla, California, United States
- Tampa General Hospital Cancer Institute Tampa, Florida, United States
- Henry Ford Health System Detroit, Michigan, United States
- Gabrail Cancer Center Research Canton, Ohio, United States